Nerlynx OverviewNeratinib (INN; trade name Nerlynx; development code HKI-272) is a tyrosine kinase inhibitor anticancer drug. Contents 1 Medical use 2 Adverse effects 3 Interactions 4 Pharmacology 5 Chemistry 6 History 7 Brand names 8 References 9 External links Medical use Neratinib is used as an adjuvant therapy in people with: - early stage breast cancer in which HER2 is overexpressed, after the person receives treatment with trastuzumab. -...
Read more Nerlynx Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Neratinib
Recent Nerlynx Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Tablet: 40mg
NDC Database Records for Nerlynx: (1 result)Sorted by National Drug Code
- 70437-240 Nerlynx 48.31 mg Oral Tablet by Puma Biotechnology, Inc.